Behavioral Health
California has long struggled to revitalize its behavioral health system and expand its workforce to meet residents' needs.
The FDA is revising the labeling of all extended-release ADHD medications to warn about adverse reactions in young children.
Behavioral Healthcare AI, Part 2: Detecting Suicide Risk for Earlier Intervention
Behavioral Healthcare AI, Part 1: Improving Access & Measurement-Based Care
patients at highest risk for suicided can be more readily identified with a single Suicide Cognitions Scale item—a very ...
Young adults exposed to inpatient hospitalizations, EDs, or mental health facilities had an increased risk for opioid misuse ...
Anxiety and depressive symptoms, although common in patients with COPD, are not frequently assessed, identified, and treated ...
Adverse childhood experiences (ACEs) are associated with a greater risk for many common conditions that contribute to…
180 Mount Airy Road Suite 205
Basking Ridge, NJ 07920
Connect
The content of this site is intended for healthcare professionals.
© 2025 Physician’s Weekly, a Formedics PropertyAny views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.